![]() ![]() The BD SurePath™ Liquid-based Pap Test combined with the BD FocalPoint™ GS Imaging System provides the Summit Medical Group laboratory with a comprehensive solution for the best patient outcomes. In order to ensure the most accurate diagnosis is made, specimen sampling, preparation, and imaging are all critical components for the detection of this disease. ![]() and nearly one out of four women diagnosed will die from their disease. Over 11,000 cases of cervical cancer are still diagnosed annually in the U.S. The instrument then directs cytotechnologist and pathologist to areas or fields of view on each patient’s (microscope) slide likely to contain abnormality. Utilizing sophisticated interpretation software and over 100 object analysis algorithms, the BD FocalPoint™ GS Imaging system provides information regarding changes in cell morphology as well as specimen adequacy. Clinical trials for the BD FocalPoint™ GS Imaging system demonstrated a statistically significant increase in disease detection in the most important precancerous disease categories and a 24.5% improvement in cancer detection in comparison to current manual methods. Approved by the FDA for screening BD SurePath™ Pap test slides, it provides further improvements in cervical disease detection. Summit Medical Group now employs the BD FocalPoint™ GS Imaging System developed by BD Diagnostics – Women’s Health and Cancer (Franklin Lakes, NJ). Computer-assisted screening provides the latest advancement for cervical cancer detection.īerkeley Heights, NJ (PRWEB) - Summit Medical Group today announced it has begun using state-of-the-art technology designed to improve diagnosis of cervical cancer and its precursors. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |